These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 25433106)
1. Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients. Díez Rodríguez R; Ballesteros Pomar MD; Calleja Fernández A; Calleja Antolin S; Cano Rodríguez I; Linares Torres P; Jorquera Plaza F; Olcoz Goñi JL Nutr Hosp; 2014 Dec; 30(6):1256-62. PubMed ID: 25433106 [TBL] [Abstract][Full Text] [Related]
2. [The influence of bariatric surgery on calcium homeostasis and biochemical markers of bone turnover in patients with morbid obesity]. Czerwińska E; Marcinowska-Suchowierska E; Walicka M; Lisik W; Wierzbicki Z Endokrynol Pol; 2007; 58(2):130-8. PubMed ID: 17578829 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Schindler K; Würger T; Wrba F; Trauner M; Prager G; Ludvik B Obes Surg; 2016 Oct; 26(10):2425-32. PubMed ID: 26989059 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]
5. Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients. Anty R; Hastier A; Canivet CM; Patouraux S; Schneck AS; Ferrari-Panaia P; Ben-Amor I; Saint-Paul MC; Gugenheim J; Gual P; Iannelli A; Tran A Obes Surg; 2016 Sep; 26(9):2138-2143. PubMed ID: 26787197 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients. Díez-Rodríguez R; Ballesteros-Pomar MD; Calleja-Fernández A; González-De-Francisco T; González-Herráez L; Calleja-Antolín S; Cano-Rodríguez I; Olcoz-Goñi JL Rev Esp Enferm Dig; 2014 Dec; 106(8):522-8. PubMed ID: 25544409 [TBL] [Abstract][Full Text] [Related]
7. Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density. Eshraghian A Minerva Endocrinol; 2017 Jun; 42(2):164-172. PubMed ID: 27973461 [TBL] [Abstract][Full Text] [Related]
8. Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. Hekimian G; Boutten A; Flamant M; Duval X; Dehoux M; Benessiano J; Huart V; Dupré T; Berjeb N; Tubach F; Iung B; Vahanian A; Messika-Zeitoun D Eur Heart J; 2013 Jul; 34(25):1915-22. PubMed ID: 23329150 [TBL] [Abstract][Full Text] [Related]
9. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia. Okten A; Cakir M; Makuloglu M Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894 [TBL] [Abstract][Full Text] [Related]
10. Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density. Balsa JA; Botella-Carretero JI; Peromingo R; Caballero C; Muñoz-Malo T; Villafruela JJ; Arrieta F; Zamarrón I; Vázquez C Obes Surg; 2010 Apr; 20(4):468-73. PubMed ID: 19937150 [TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
12. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Pugnale N; Giusti V; Suter M; Zysset E; Héraïef E; Gaillard RC; Burckhardt P Int J Obes Relat Metab Disord; 2003 Jan; 27(1):110-6. PubMed ID: 12532162 [TBL] [Abstract][Full Text] [Related]
13. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction. Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953 [TBL] [Abstract][Full Text] [Related]
14. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919 [TBL] [Abstract][Full Text] [Related]
15. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693 [TBL] [Abstract][Full Text] [Related]
16. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. Lecube A; Valladares S; López-Cano C; Gutiérrez L; Ciudin A; Fort JM; Reñé JM; Matias-Guiu X; de Torres I; Bueno M; Pallarés J; Baena JA PLoS One; 2016; 11(11):e0166741. PubMed ID: 27893763 [TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease. Barchetta I; Lubrano C; Cimini FA; Dule S; Passarella G; Dellanno A; Di Biasio A; Leonetti F; Silecchia G; Lenzi A; Cavallo MG Hepatol Int; 2023 Apr; 17(2):357-366. PubMed ID: 36520377 [TBL] [Abstract][Full Text] [Related]